However, both medications independently affect the gastrointestinal system, which requires careful consideration when used together
What was studied: Cardiovascular death and worsening of heart failure over a median follow-up of roughly two years Outcome: Tirzepatide reduced the combined risk of cardiovascular death and worsening heart failure events by approximately 38%, driven largely by a 46% reduction in worsening heart failure events requiring hospitalization or urgent care
For dry and sensitive skin
TMAO and Chronic Coronary Artery Disease In recent years, several studies have suggested that TMAO is a new independent risk factor for atherosclerosis (Table 1)
Milani A, Basirnejad M, Shahbazi S, Bolhassani A
Each COA includes the batch identifier, test date, testing method, and verified purity percentage